Navin Fluorine’s Q1 FY27: Strong growth, expanding margins, and a capex calendar investors can track

Navin Fluorine International Limited opened FY27 with a sharp step-up in scale and profitability. In Q1 FY27, consolidated revenue from operations rose to Rs. 1,045.08 crore, up 44 percent year on year and 11 percent quarter on quarter. Operating EBITDA grew faster than revenue, reaching Rs. 357.07 crore, up 73 percent year on year, with an operating EBITDA margin of 34.2 percent. Profit after tax more than doubled year on year to Rs. 243.31 crore.

The quarter’s story is not only the headline numbers. The company’s three business verticals, High Performance Products, Specialty Chemicals, and CDMO (Contract Development and Manufacturing Organisation), all reported year on year growth. At the same time, management outlined a set of commissioning timelines across multiple capex projects. For investors, this combination matters because it makes the next 12 to 24 months measurable: projects have amounts, and projects have dates.

A three-vertical growth quarter, led by CDMO momentum

Navin Fluorine’s Q1 FY27 revenue base was supported by all three verticals. The presentation reports year on year revenue growth of 33 percent in High Performance Products (HPP), 48 percent in Specialty Chemicals, and 82 percent in CDMO.

On an absolute basis, segment revenues disclosed for Q1 FY27 were Rs. 540 crore for HPP, Rs. 325 crore for Specialty Chemicals, and Rs. 180 crore for CDMO. HPP remained the largest contributor in the quarter, while CDMO showed the fastest growth rate.

In HPP, management attributed growth to volume and higher realisations. The pricing environment for Hydrofluorocarbons was described as constructive, and the company pointed to increasing interest for contractual offtakes in new capacities. The quarter also benefited from progress on the anhydrous hydrofluoric acid facility, which commenced operations in Q4 FY26 and is being ramped up.

Specialty Chemicals growth was positioned as more pipeline-driven, with management citing strong order visibility, meaningful scale-up across existing molecules, and a line-up of new launches. The company also highlighted project execution, including a Chemours-linked initiative targeted for completion by end of Q2 FY27 and a multi purpose plant de-bottlenecking project at Dahej targeted for commissioning in Q3 FY27.

CDMO performance was described as being backed by an order book and deeper engagement with a European CDMO major. The presentation ties growth to increasing demand for an existing molecule and expansion of Navin Fluorine’s footprint in the partner’s supply chain. CDMO, in this disclosure set, is heavily export oriented, with a geographic mix shown as 98 percent outside India and 2 percent domestic.

FY26 profitability reset and what it enables in FY27

While the quarter was strong, FY26 provides the broader context for the company’s financial positioning. Consolidated revenue from operations increased to Rs. 3,313.90 crore in FY26 from Rs. 2,349.38 crore in FY25, a 41 percent rise. More important, operating EBITDA more than doubled to Rs. 1,081.68 crore in FY26 from Rs. 533.72 crore in FY25, and operating EBITDA margin expanded to 32.6 percent from 22.7 percent.

This profitability reset matters because Navin Fluorine is running a multi-project capex program across its verticals. The company repeatedly notes that several projects are funded through internal accruals, and stronger operating profitability can support that approach while limiting balance sheet strain.

The company also continues to communicate shareholder returns through a long dividend track record. The presentation shows progressive dividends across multiple years and discloses payout percentage on a standalone basis, with FY26 payout shown at 16 percent.

A capex calendar with commissioning dates: HFC, MPP, CDMO, and Advanced Materials

The most decision-useful part of the presentation is how it frames investments with scope, capex, and targeted commissioning timelines. It is not a single bet. It is a portfolio of expansions, each tied to a different driver.

In High Performance Products, Navin Fluorine is adding additional Hydrofluorocarbon capacity equivalent up to 15,000 metric tonnes per annum of R32. The company disclosed capex of Rs. 236.5 crore, to be funded by internal accruals, and expects commissioning by Q3 FY27. It also quantified peak revenue potential at about Rs. 600 to 825 crore per annum. The rationale is tied to global demand-supply conditions shaped by the transition to low global warming potential gases and rising room air conditioner and blends demand in India and export markets.

In Specialty Chemicals, the Dahej multi purpose plant de-bottlenecking project has capex of Rs. 75 crore, with commissioning targeted by Q3 FY27. The company linked this project to launch of a new molecule for a global innovator and disclosed peak revenue potential of about Rs. 140 to 160 crore per annum. It also stated that a purchase order has been received for calendar year 2026.

The Chemours project is positioned under Advanced Materials. Navin Fluorine disclosed capex of Rs. 120 crore for initial commercial capacity to enable adoption of an innovative liquid cooling product. Commissioning is targeted by Q2 FY27, and 35 percent of the capex is funded by the customer, with the balance through internal accruals. The company did not disclose peak revenue potential, stating it is under confidentiality.

In CDMO, the company reiterated that its board had already approved cGMP4 capex of Rs. 288 crore in February 2024. Phase I was operationalized in Q3 FY26. The presentation states Phase II capex of Rs. 125 crore has been initiated and is expected to be operational by Q4 FY27. The stated driver is increasing demand for an existing molecule from a European CDMO major and expansion in the partner’s supply chain. The company also indicated a peak asset turnover of about 3x.

Finally, the company is incubating a new Advanced Materials vertical aimed at niche applications in data centers, electronics, defence, and semiconductors. To support commercial qualification supplies, it disclosed an additional capex plan of Rs. 90 crore to set up adoption capacities, with completion by Q2 FY28.

Sustainability and governance: measurable targets, mixed progress

Navin Fluorine’s ESG disclosures include medium-term targets such as a 30 percent reduction in carbon emissions by 2030 from the base year 2023 and a target of 50 percent use of renewable electricity by 2030. In the progress section for FY 2025-26, the company reports renewable electricity usage at 12.15 percent.

The company also disclosed an investment of Rs. 15.73 crore in a special purpose vehicle for a 14.9 megawatt hybrid power plant across NFIL and NFASL. The stated intent is to reinforce sustainability through increased renewable energy adoption and progress towards decarbonization goals, and the presentation claims this could lead to over 60 percent of energy needs being met from renewable sources.

At the same time, the progress data shows an 11.1 percent increase in specific carbon emissions in carbon dioxide per tonne of production in 2026. On governance, the company’s targets include 100 percent resolution of complaints, while progress shown for 2026 is 89.24 percent.

Takeaways for investors

Navin Fluorine’s Q1 FY27 results reflect strong execution, with consolidated revenue and profits rising sharply and margins holding above 34 percent at the operating EBITDA level. What makes the current phase more investable for analysts is the clarity of the capex roadmap. The company has disclosed project sizes, timelines, and in some cases peak revenue potential.

The next phase of the story is likely to be judged less on quarterly beats and more on commissioning discipline. HFC expansion by Q3 FY27, the Chemours project by Q2 FY27, the Dahej de-bottlenecking by Q3 FY27, and cGMP4 Phase II by Q4 FY27 are now trackable milestones. If delivered on time and supported by customer demand, they can extend the scale-up seen in FY26 and early FY27 into a more durable growth runway.